Recombinant human erythropoietin alfa (drug)

DRUG2 trials

Sponsors

Yale University

Conditions

Healthy SubjectsMyocardial Infarction

Phase 2

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

CompletedNCT00368238

Yale UniversityHealthy Subjects

Start: 2005-10-31End: 2006-07-31Target: 96Updated: 2006-08-24

Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction

CompletedNCT00367991

Yale UniversityMyocardial Infarction

Start: 2006-11-30End: 2008-03-31Updated: 2018-01-12